(Q28319229)

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

30 April 2022

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

30 April 2022

author name string

T. Di Paolo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A116893

30 April 2022

R. Carmichael

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A116893

30 April 2022

F. Labrie

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A116893

30 April 2022

J. P. Raynaud

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A116893

full work available at URL

30 April 2022

language of work or name

English

0 references

publication date

November 1979

0 references

https://api.elsevier.com/content/article/PII:0303720779901084?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

https://api.elsevier.com/content/article/PII:0303720779901084?httpAccept=text/plain

30 April 2022

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Molecular and Cellular Endocrinology

30 April 2022

published in

0 references

volume

16

0 references

issue

2

0 references

page(s)

99-112

0 references

cites work

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

3

20

415

Bernheimer

1973

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

30 April 2022

5

196

326

Burt

1976

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

3H-spiroperidol labels dopamine receptors in pituitary and brain

30 April 2022

6

46

377

Creese

1977

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas

30 April 2022

7

278

252

De Camilli

1979

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Effect of estrogen on changes in the activity of striatal cholinergic neurons induced by DA drugs

30 April 2022

9

169

215

Euvrard

1979

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Antidopaminergic activity of estrogens on prolactin release at the pituitary level in vivo

30 April 2022

10

14

199

Ferland

1978

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Structural and Functional Properties of the Acetylcholine Receptor Protein in its Purified and Membrane-Bound States

30 April 2022

12

47

317

Heidmann

1978

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Parkinsons disease and its chemotherapy

30 April 2022

13

24

1061

Hornykiewicz

1975

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Multiple receptors for dopamine

30 April 2022

14

277

93

Kebabian

1979

0 references

The pharmacology of tardive dyskinesias

16

130

82

Klawans

1973

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Receptor basis for dopaminergic supersensitivity in Parkinson's disease

30 April 2022

22

273

59

Lee

1978

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Calcium-dependent stimulation of prolactin release in rat anterior pituitary in vitro by n(6)-monobutyryl adenosine 3',5'-monophosphate

30 April 2022

23

20

7

Lemay

1972

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors

30 April 2022

25

21

1751

Müller

1977

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Direct evidence for presynaptic and postsynaptic dopamine receptors in brain

30 April 2022

27

274

278

Nagy

1978

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Potent Antidopaminergic Activity of Estradiol at the Pituitary Level on Prolactin Release

30 April 2022

29

200

1173

Raymond

1978

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Apparent positive cooperative effects in cyclic AMP and corticosterone production by isolated adrenal cells in response to ACTH analogues.

30 April 2022

30

94

1427

Rodbard

1974

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

30 April 2022

32

51

660

Scatchard

1949

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum

30 April 2022

33

271

766

Schwarcz

1978

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase

30 April 2022

34

23

465

Schwarcz

1978

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine

30 April 2022

0 references

Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

36

13

927

Tarsy

1974

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

Treatment of drug-induced dyskinesias

30 April 2022

37

I

353

Villeneuve

1970

1 reference

https://api.crossref.org/works/10.1016/0303-7207(79)90108-4

30 April 2022

Identifiers

0 references